84
50
Growth Score 84 in past quarter
-2 pts
Heat Score 50 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3628617
Si Legend develops a therapeutic drug for intractable retinal disease.
- Tadahisa Kagimoto: President / Founder
About the Company
Si Legend develops a therapeutic drug for intractable retinal disease. Retinal pigment epithelial cells derived from iPS cells will be produced and put into practical use as pharmaceuticals.